Diabetes, Vol 48, Issue 4 699-705, Copyright © 1999 by American Diabetes Association

ARTICLES

Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes

J Rieusset, F Andreelli, D Auboeuf, M Roques, P Vallier, JP Riou, J Auwerx, M Laville and H Vidal
INSERM U449 and the Human Nutrition Research Center of Lyon, France. rieusset@cimac-res.univ-lyon1.fr

Peroxisome proliferator-activated receptor (PPAR)-gamma is one of the key actors of adipocyte differentiation. This study demonstrates 1) that PPAR-gamma mRNA expression is not altered in subcutaneous adipose tissue (n = 44) or in skeletal muscle (n = 19) of subjects spanning a wide range of BMIs (20-53 kg/m2) and 2) that insulin acutely increases PPAR-gamma mRNA expression in human adipocytes both in vivo and in vitro. The effect of insulin was investigated in abdominal subcutaneous biopsies obtained before and at the end of a 3-h euglycemic-hyperinsulinemic clamp. Insulin significantly increased PPAR-gamma mRNA levels in lean subjects (88 +/- 17%, n = 6), in type 2 diabetic patients (100 +/- 19%, n = 6), and in nondiabetic obese patients (91 +/- 20%, n = 6). Both PPAR-gamma1 and PPAR-gamma2 mRNA variants were increased (P < 0.05) after insulin infusion. In isolated human adipocytes, insulin induced the two PPAR-gamma mRNAs in a dose-dependent manner, with half-maximal stimulation at a concentration of approximately 1-5 nmol/l. However, PPAR-gamma2 mRNA was rapidly (2 h) and transiently increased, whereas a slow and more progressive induction of PPAR-gamma1 was observed during the 6 h of incubation. In explants of human adipose tissue, PPAR-gamma protein levels were significantly increased (42 +/- 3%, P < 0.05) after 12 h of incubation with insulin. These data demonstrate that PPAR-gamma belongs to the list of the insulin-regulated genes and that obesity and type 2 diabetes are not associated with alteration in the expression of this nuclear receptor in adipose tissue.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L Dubuquoy, C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, and P Desreumaux PPAR{gamma} as a new therapeutic target in inflammatory bowel diseases. Gut, September 1, 2006; 55(9): 1341 - 1349. [Full Text] [PDF]

				S. A Bayol, B. H Simbi, and N. C Stickland A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning J. Physiol., September 15, 2005; 567(3): 951 - 961. [Abstract] [Full Text] [PDF]

				N. M. Al-Rasheed, R. S. Chana, R. J. Baines, G. B. Willars, and N. J. Brunskill Ligand-independent Activation of Peroxisome Proliferator-activated Receptor-{gamma} by Insulin and C-peptide in Kidney Proximal Tubular Cells: DEPENDENT ON PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY J. Biol. Chem., November 26, 2004; 279(48): 49747 - 49754. [Abstract] [Full Text] [PDF]

				N. M. Morton, J. M. Paterson, H. Masuzaki, M. C. Holmes, B. Staels, C. Fievet, B. R. Walker, J. S. Flier, J. J. Mullins, and J. R. Seckl Novel Adipose Tissue-Mediated Resistance to Diet-Induced Visceral Obesity in 11{beta}-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice Diabetes, April 1, 2004; 53(4): 931 - 938. [Abstract] [Full Text] [PDF]

				V. Giusti, C. Verdumo, M. Suter, R. C. Gaillard, P. Burckhardt, and F. Pralong Expression of Peroxisome Proliferator-Activated Receptor-{gamma}1 and Peroxisome Proliferator-Activated Receptor-{gamma}2 in Visceral and Subcutaneous Adipose Tissue of Obese Women Diabetes, July 1, 2003; 52(7): 1673 - 1676. [Abstract] [Full Text] [PDF]

				M. L. Martelli, R. Iuliano, I. Le Pera, I. Sama', C. Monaco, S. Cammarota, T. Kroll, L. Chiariotti, M. Santoro, and A. Fusco Inhibitory Effects of Peroxisome Proliferator-Activated Receptor {gamma} on Thyroid Carcinoma Cell Growth J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4728 - 4735. [Abstract] [Full Text] [PDF]

				C. P. Sewter, F. Blows, A. Vidal-Puig, and S. O'Rahilly Regional Differences in the Response of Human Pre-Adipocytes to PPAR{gamma} and RXR{alpha} Agonists Diabetes, March 1, 2002; 51(3): 718 - 723. [Abstract] [Full Text] [PDF]

				Z. E. Floyd and J. M. Stephens Interferon-gamma -mediated Activation and Ubiquitin-Proteasome-dependent Degradation of PPARgamma in Adipocytes J. Biol. Chem., February 1, 2002; 277(6): 4062 - 4068. [Abstract] [Full Text] [PDF]

				N. M. Lapsys, A. D. Kriketos, M. Lim-Fraser, A. M. Poynten, A. Lowy, S. M. Furler, D. J. Chisholm, and G. J. Cooney Expression of Genes Involved in Lipid Metabolism Correlate with Peroxisome Proliferator-Activated Receptor {gamma} Expression in Human Skeletal Muscle J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4293 - 4297. [Abstract] [Full Text]

				N. Zeghari, H. Vidal, M. Younsi, O. Ziegler, P. Drouin, and M. Donner Adipocyte membrane phospholipids and PPAR-gamma expression in obese women: relationship to hyperinsulinemia Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E736 - E743. [Abstract] [Full Text] [PDF]

				M. R. Sartippour and G. Renier Differential Regulation of Macrophage Peroxisome Proliferator-Activated Receptor Expression by Glucose : Role of Peroxisome Proliferator-Activated Receptors in Lipoprotein Lipase Gene Expression Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 104 - 110. [Abstract] [Full Text] [PDF]

				B. Desvergne and W. Wahli Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism Endocr. Rev., October 1, 1999; 20(5): 649 - 688. [Abstract] [Full Text]

				L. Li, J. Tao, J. Davaille, C. Feral, A. Mallat, J. Rieusset, H. Vidal, and S. Lotersztajn 15-Deoxy-Delta 12,14-prostaglandin J2 Induces Apoptosis of Human Hepatic Myofibroblasts. A PATHWAY INVOLVING OXIDATIVE STRESS INDEPENDENTLY OF PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTORS J. Biol. Chem., October 5, 2001; 276(41): 38152 - 38158. [Abstract] [Full Text] [PDF]